Filter Results:
(1,008)
Show Results For
- All HBS Web
(1,008)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Show Results For
- All HBS Web
(1,008)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (A)
By: Sandra J. Sucher and Stacy McManus
Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the... View Details
Keywords: Decision Making; Health Testing and Trials; Innovation and Invention; Markets; Distribution; Product Development; Production; Problems and Challenges; Research; Research and Development; Complexity; Biotechnology Industry; Pharmaceutical Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- June 2021
- Case
uBiome
By: Thomas R. Eisenmann and Olivia Graham
uBiome provided clinical tests that sequenced the DNA of human microbiome samples, providing data on health conditions directly to consumers or to prescribing physicians. Founded in 2012, the San Francisco-based startup raised $105 million from top-tier venture capital... View Details
- 17 Aug 2021
- Research & Ideas
Can Autonomous Vehicles Drive with Common Sense?
Julian De Freitas. “We expect that they will make roads truly much safer.” In fact, De Freitas and colleagues recently argued in the Proceedings of the National Academy of Sciences that adopting driverless vehicles on a broad scale could... View Details
- 01 Apr 2015
- Research & Ideas
The Slow, Steady Battle to Fix Cancer Care
with insurance provider UnitedHealthcare to test a fixed-payment structure for a select group of head and neck cancer patients. Rather than receiving separate charges for every test, treatment, View Details
- December 2016 (Revised January 2017)
- Case
Nutrition Science Initiative: Are All Calories Created Equal?
By: Kevin Schulman and Matan Dabora
In 2012, Gary Taubes lunched the Nutrition Science Initiative (NuSI), a not-for-profit organization aiming to question the mainstream scientific paradigm regarding obesity and dietary recommendations. This case provides a brief scientific background on obesity and its... View Details
Schulman, Kevin, and Matan Dabora. "Nutrition Science Initiative: Are All Calories Created Equal?" Harvard Business School Case 317-033, December 2016. (Revised January 2017.)
- Profile
Arjun Goyal
Trust Centre for Human Genetics, a new door opened for Arjun. “It was my first exposure to research,” he says. “It fascinated me that the test tube in my hand could hold a new cure or the next new therapy for controlling a disease.”... View Details
- July 2023
- Case
DayTwo: Going to Market with Gut Microbiome (Abridged)
By: Ayelet Israeli
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in... View Details
Keywords: Business Startups; AI and Machine Learning; Nutrition; Market Entry and Exit; Product Marketing; Distribution Channels
Israeli, Ayelet. "DayTwo: Going to Market with Gut Microbiome (Abridged)." Harvard Business School Case 524-015, July 2023.
- January 2022
- Article
Rational Habit Formation: Experimental Evidence from Handwashing in India
By: Reshmaan Hussam, Atonu Rabbani, Giovanni Reggiani and Natalia Rigol
We test the predictions of the rational addiction model, reconceptualized as rational habit formation, in the context of handwashing in rural India. To track handwashing, we design soap dispensers with timed sensors. We test for rational habit formation by informing... View Details
Hussam, Reshmaan, Atonu Rabbani, Giovanni Reggiani, and Natalia Rigol. "Rational Habit Formation: Experimental Evidence from Handwashing in India." American Economic Journal: Applied Economics 14, no. 1 (January 2022): 1–41. (Lead Article.)
- Research Summary
Overview
The Information Age has introduced well recieved opportunities to track performance. Fitbits and Fuelbands show individuals their own performance; service companies including Uber and leading hospitals help pick from drivers or doctors based on how others rate them;... View Details
- September 2020 (Revised July 2021)
- Case
Moderna (A)
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital... View Details
Keywords: COVID-19; Vaccine; Digital Organizations; Organizational Structure; Operations; Management; Health Pandemics; Research and Development; Goals and Objectives
Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised July 2021.)
- April 1993 (Revised November 1994)
- Case
Chiron Corp.
Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
Keywords: Health Testing and Trials; Research and Development; Failure; Business Strategy; Joint Ventures; Strategic Planning; Opportunities; Product Development; Biotechnology Industry; California
Wheelwright, Steven C. "Chiron Corp." Harvard Business School Case 693-052, April 1993. (Revised November 1994.)
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia's drug candidate through Clinical 2 trials with a to-market goal... View Details
- July 2013
- Case
Montreaux Chocolate USA: Are Americans Ready for Healthy Dark Chocolate?
By: John A. Quelch and Diane Badame
Andrea Torres, director of new product development at a high-end chocolate confectionery company, leads her team through a carefully sequenced program of market research to support the development and launch of a new product, healthy dark chocolate with fruit. This is... View Details
Keywords: Competition; Food; Consumer Behavior; Nutrition; Product Launch; Product Development; Food and Beverage Industry; Switzerland; United States
Quelch, John A., and Diane Badame. "Montreaux Chocolate USA: Are Americans Ready for Healthy Dark Chocolate?" Harvard Business School Brief Case 914-501, July 2013.
- February 2008
- Case
SPECIALISTERNE: Sense & Details
Three-quarters of Specialisterne's expert software testing staff are diagnosed with some form of Autistic Spectrum Disorder (ASD). Usually a handicap, ASD conveys talents especially suited to software testing and other highly repetitive tasks that require very high... View Details
Keywords: Business Model; For-Profit Firms; Health Disorders; Employees; Performance Evaluation; Quality; Software; Information Technology Industry
Austin, Robert D., Jonathan Wareham, and Javier Busquets. "SPECIALISTERNE: Sense & Details." Harvard Business School Case 608-109, February 2008.
- October 1976 (Revised February 1987)
- Case
Cramer Electronics, Inc.
Designed to be the second day of a two-day series on the electronic component distribution industry, following a day spent discussing Note on the Electronic Component Distribution Industry and Raytheon Co.: Diversification. The important teaching themes which this case... View Details
Keywords: Change Management; Innovation Strategy; Management Style; Resource Allocation; Opportunities; Corporate Strategy; Diversification; Distribution Industry; Electronics Industry
Porter, Michael E. "Cramer Electronics, Inc." Harvard Business School Case 377-063, October 1976. (Revised February 1987.)
- 30 Mar 2020
- News
Why Is the U.S. Behind on Coronavirus Testing?
- January 2020
- Article
The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System
By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details
Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
- 23 Jul 2020
- News